HIV Citation List: January 31 - February 13, 2014

PubMed citations

1. Specific Features of HIV-1 Integrase Inhibition by Bisphosphonate Derivatives.Agapkina, J., D. Yanvarev, A. Anisenko, S. Korolev, J. Vepsalainen, S. Kochetkov, and M. Gottikh. European Journal of Medicinal Chemistry, 2014. 73: p. 73-82. PMID[24378711].

[PubMed]. HIV_0131-021314.

2. Discovery of HIV-1 Integrase Inhibitors: Pharmacophore Mapping, Virtual Screening, Molecular Docking, Synthesis, and Biological Evaluation.Bhatt, H., P. Patel, and C. Pannecouque. Chemical Biology & Drug Design, 2014. 83(2): p. 154-166. PMID[23957390].

[PubMed]. HIV_0131-021314.

3. Evaluation of PD 404,182 as an anti-HIV and anti-Herpes Simplex Virus Microbicide.Chamoun-Emanuelli, A.M., M. Bobardt, B. Moncla, M.K. Mankowski, R.G. Ptak, P. Gallay, and Z. Chen. Antimicrobial Agents and Chemotherapy, 2014. 58(2): p. 687-697. PMID[24217696].

[PubMed]. HIV_0131-021314.

4. Discovery of MK-1439, an Orally Bioavailable Non-Nucleoside Reverse Transcriptase Inhibitor Potent against a Wide Range of Resistant Mutant HIV Viruses.Cote, B., J.D. Burch, E. Asante-Appiah, C. Bayly, L. Bedard, M. Blouin, L.C. Campeau, E. Cauchon, M. Chan, A. Chefson, N. Coulombe, W. Cromlish, S. Debnath, D. Deschenes, K. Dupont-Gaudet, J.P. Falgueyret, R. Forget, S. Gagne, D. Gauvreau, M. Girardin, S. Guiral, E. Langlois, C.S. Li, N. Nguyen, R. Papp, S. Plamondon, A. Roy, S. Roy, R. Seliniotakis, M. St-Onge, S. Ouellet, P. Tawa, J.F. Truchon, J. Vacca, M. Wrona, Y. Yan, and Y. Ducharme. Bioorganic & Medicinal Chemistry Letters, 2014. 24(3): p. 917-922. PMID[24412110].

[PubMed]. HIV_0131-021314.

5. A Combination Microbicide Gel Protects Macaques against Vaginal Simian Human Immunodeficiency Virus-Reverse Transcriptase Infection, but Only Partially Reduces Herpes Simplex Virus-2 Infection after a Single High-dose Cochallenge.Hsu, M., M. Aravantinou, R. Menon, S. Seidor, D. Goldman, J. Kenney, N. Derby, A. Gettie, J. Blanchard, M. Piatak, Jr., J.D. Lifson, J.A. Fernandez-Romero, T.M. Zydowsky, and M. Robbiani. AIDS Research and Human Retroviruses, 2014. 30(2): p. 174-183. PMID[24117013].

[PubMed]. HIV_0131-021314.

6. Artificial Nucleobase-amino acid Conjugates: A New Class of TAR RNA Binding Agents.Joly, J.P., G. Mata, P. Eldin, L. Briant, F. Fontaine-Vive, M. Duca, and R. Benhida. Chemistry, 2014. 20(7): p. 2071-2079. PMID[24431237].

[PubMed]. HIV_0131-021314.

7. Design and Synthesis of Novel Distamycin-modified Nucleoside Analogues as HIV-1 Reverse Transcriptase Inhibitors. Li, C., C. Ma, J. Zhang, N. Qian, J. Ding, R. Qiao, and Y. Zhao. Antiviral research, 2014. 102: p. 54-60. PMID[24342709].

[PubMed]. HIV_0131-021314.

8. Structure-Activity Relationships of Diamine Inhibitors of Cytochrome P450 (CYP) 3A as Novel Pharmacoenhancers, Part I: Core Region. Liu, H., L. Xu, H. Hui, R. Vivian, C. Callebaut, B.P. Murray, A. Hong, M.S. Lee, L.K. Tsai, J.K. Chau, K.M. Stray, C. Cannizzaro, Y.C. Choi, G.R. Rhodes, and M.C. Desai. Bioorganic & Medicinal Chemistry Letters, 2014. 24(3): p. 989-994. PMID[24411125].

[PubMed]. HIV_0131-021314.

9. Design, Synthesis, Antimicrobial Activity and anti-HIV Activity Evaluation of Novel Hybrid Quinazoline-triazine Derivatives. Modh, R.P., E. De Clercq, C. Pannecouque, and K.H. Chikhalia. Journal of Enzyme Inhibition and Medicinal Chemistry, 2014. 29(1): p. 100-108. PMID[23327639]. [PubMed]. HIV_0131-021314.

10. Purified Human Breast Milk MUC1 and MUC4 Inhibit Human Immunodeficiency Virus.Mthembu, Y., Z. Lotz, M. Tyler, C. de Beer, J. Rodrigues, L. Schoeman, and A.S. Mall. Neonatology, 2014. 105(3): p. 211-217. PMID[24503884].

[PubMed]. HIV_0131-021314.

11. Synthesis, Biophysical Characterization and anti-HIV Activity of d(TG3AG) Quadruplexes Bearing Hydrophobic Tails at the 5'-End. Romanucci, V., D. Milardi, T. Campagna, M. Gaglione, A. Messere, A. D'Urso, E. Crisafi, C. La Rosa, A. Zarrelli, J. Balzarini, and G. Di Fabio. Bioorganic & Medicinal Chemistry, 2014. 22(3): p. 960-966. PMID[24433967].

[PubMed]. HIV_0131-021314.

12. Structure-Activity Relationships of Diamine Inhibitors of Cytochrome P450 (CYP) 3A as Novel Pharmacoenhancers. Part II: P2/P3 Region and Discovery of Cobicistat (GS-9350).Xu, L., H. Liu, A. Hong, R. Vivian, B.P. Murray, C. Callebaut, Y.C. Choi, M.S. Lee, J. Chau, L.K. Tsai, K.M. Stray, R.G. Strickley, J. Wang, L. Tong, S. Swaminathan, G.R. Rhodes, and M.C. Desai. Bioorganic & Medicinal Chemistry Letters, 2014. 24(3): p. 995-999. PMID[24412072].

[PubMed]. HIV_0131-021314.

ISI Web of Knowledge Citations

13. Exceptionally Potent and Broadly Cross-reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains.Chen, W.Z., Y. Feng, P. Prabakaran, T.L. Ying, Y.P. Wang, J.P. Sun, C.D.S. Macedo, Z.Y. Zhu, Y.X. He, V.R. Polonis, and D.S. Dimitrov. Journal of Virology, 2014. 88(2): p. 1125-1139. ISI[000329194900034].

[WOS]. HIV_0131-021314.

14. A Candidate anti-HIV Reservoir Compound, Auranofin, Exerts a Selective 'Anti-memory' Effect by Exploiting the Baseline Oxidative Status of Lymphocytes. Chirullo, B., R. Sgarbanti, D. Limongi, I.L. Shytaj, D. Alvarez, B. Das, A. Boe, S. DaFonseca, N. Chomont, L. Liotta, E. Petricoin, S. Norelli, E. Pelosi, E. Garaci, A. Savarino, and A.T. Palamara. Cell Death & Disease, 2013. 4; p. e944. ISI[000329161300005].

[WOS]. HIV_0131-021314.

15. Diverse Modifications of the 4-Methylphenyl Moiety of TAK-779 by Late-stage Suzuki-Miyaura Cross-coupling. Junker, A., D. Schepmann, J. Yamaguchi, K. Itami, A. Faust, K. Kopka, S. Wagner, and B. Wunsch. Organic & Biomolecular Chemistry, 2014. 12(1): p. 177-186. ISI[000329551100021].

[WOS]. HIV_0131-021314.

16. Substrate-specific Inactivation of CYP3A by the HIV Protease Inhibitors Ritonavir, Saquinavir and Amprenavir. Kazmi, F., P. Yerino, K. Goodell, B. Kirby, B.W. Ogilvie, D.B. Buckley, and J. Unadkat. Drug Metabolism Reviews, 2014. 45: p. 133-134. ISI[000329445700270].

[WOS]. HIV_0131-021314.

17. Kadcotriones A-C: Tricyclic Triterpenoids from Kadsura coccinea.Liang, C.Q., Y.M. Shi, X.Y. Li, R.H. Luo, Y. Li, Y.T. Zheng, H.B. Zhang, W.L. Xiao, and H.D. Sun. Journal of Natural Products, 2013. 76(12): p. 2350-2354. ISI[000329331200024].

[WOS]. HIV_0131-021314.

18. Exosomes from Breast Milk Inhibit HIV-1 Infection of Dendritic Cells and Subsequent Viral Transfer to CD4(+) T Cells. Naslund, T.I., D. Paquin-Proulx, P.T. Paredes, H. Vallhov, J.K. Sandberg, and S. Gabrielsson. AIDS, 2014. 28(2): p. 171-180. ISI[000329188800003].

[WOS]. HIV_0131-021314.

19. Anti-HIV-1 Screening of (2E)-3-(2-Chloro-6-methyl/methoxyquinolin-3-yl)-1-(aryl)prop-2-en-1-ones. Rizvi, S.U.F., M. Ahmad, M.H. Bukhari, C. Montero, P. Chatterjee, M. Detorio, and R. Schinazi. Medicinal Chemistry Research, 2014. 23(1): p. 402-407. ISI[000329607500036].

[WOS]. HIV_0131-021314.

20. Synthesis of Novel 2'-Fluoro-5'-deoxyphosphonic acids and bis(SATE) Adenine Analogue as Potent Antiviral Agents. Shen, G.H. and J.H. Hong. Bulletin of the Korean Chemical Society, 2013. 34(12): p. 3621-3628. ISI[000329144600018].

[WOS]. HIV_0131-021314.

21. The RIAD Peptidomimetic Inhibits HIV-1 Replication in Humanized NSG Mice. Singh, M., P. Singh, D. Vaira, E.A. Torheim, S. Rahmouni, K. Tasken, and M. Moutschen. European Journal of Clinical Investigation, 2014. 44(2): p. 146-152. ISI[000329579400004].

[WOS]. HIV_0131-021314.

22. Synthesis and Studies of New 6-Halo(diphenyl)methyl- and 6-(Thiophen-2-ylmethyl)pyrimidin-4(3H)-ones as Possible HIV-1 Reverse Transcriptase Inhibitors. Valuev-Elliston, V.T., A.V. Ivanov, B.S. Orlinson, E.N. Gerasimov, L.L. Brunilina, E.K. Zakharova, S.N. Kochetkov, I.A. Novakov, and M.B. Navrotskii. Russian Chemical Bulletin, 2013. 62(3): p. 797-801. ISI[000329373400027].

[WOS]. HIV_0131-021314.

Patent Citations

23. Preparation of Pyrrolo[2,3-B]pyridine Compounds as Antiviral Agents and Methods for Treating HIV. De la Rosa, M.A., B.A. Johns, W.M. Kazmierski, V. Samano, L. Suwandi, D. Temelkoff, E. Velthuisen, and J.G. Weatherhead. Patent. 2014. 2013-IB15012014009794: 213pp.

[Patent]. HIV_0131-021314.

24. M-Diarene-pyrimidine Derivatives as HIV-1 Reverse Transcriptase Inhibitors and Their Preparation, Pharmaceutical Compositions and Use in the Treatment of HIV Infection. Liu, X., X. Li, and P. Zhan. Patent. 2014. 2013-10456775103483272: 25pp.

[Patent]. HIV_0131-021314.

25. Preparation of 2-(N-Arylmethylpiperidine-4-ylamino)-4-(substituted-phenoxy)benzene Derivatives as HIV-1 Inhibitors.Liu, X. and L. Zhang. Patent. 2014. 2013-10452018103497146: 29pp.

[Patent]. HIV_0131-021314.

26. Macrocyclic Compounds as HIV Integrase Inhibitors.Reger, T., A. Walji, J. Sanders, J. Wai, and L. Wang. Patent. 2014. 2013-US499222014011769: 84pp.

[Patent]. HIV_0131-021314.

27. Preparation of Macrocyclic Compounds as HIV Integrase Inhibitors.Reger, T., A.M. Walji, J.M. Sanders, J.S. Wai, L. Hu, S. Fang, L. Wang, P. Yang, Z. Ma, and L. Sun. Patent. 2014. 2012-CN784652014008636: 90pp.

[Patent]. HIV_0131-021314.

28. The Extracellular DING Protein from CD4-Positive T Cells for Use in the Treatment of Infection. Simm, M. and R. Sachdeva. Patent. 2014. 2013-1394333720140018288: 46pp.

[Patent]. HIV_0131-021314.